New NHS treatment gives hope to thousands who suffer from common allergy
The IndependentSign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. The National Institute for Health and Care Excellence has given the green light to 12 SQ-HDM SLIT, also known as Acarizax, for individuals aged 12 to 65 suffering from persistent moderate to severe house dust mite allergic rhinitis. By administering a fixed daily dose of house dust mite allergy extract, the body builds resistance, reducing the severity of allergic reactions over time. open image in gallery A dust mite Common symptoms of allergic rhinitis include sneezing, an itchy nose, a runny or blocked nose and itchy, red and watery eyes. Helen Knight, director of medicines evaluation at Nice, said: “For people with house dust mite allergic rhinitis that is not controlled by standard treatments, this new cost-effective drug will have a significant positive impact on their quality of life.
Discover Related